Alyeska Investment Group, L.P. Cidara Therapeutics, Inc. Transaction History

Alyeska Investment Group, L.P.

  • $18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$3.75 - $6.05 $15,888 - $25,633
-4,237 Reduced 4.38%
92,564 $481,000
Q1 2018

May 15, 2018
SELL
$4.0 - $8.15 $3,492 - $7,114
-873 Reduced 0.89%
96,801 $387,000
Q3 2017

Nov 14, 2017
BUY
$5.75 - $8.1 $561,625 - $791,159
97,674
97,674 $791,000

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.24B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email